Citation: Ym. Rustum et al., RATIONALE FOR TREATMENT DESIGN - BIOCHEMICAL MODULATION OF 5-FLUOROURACIL BY LEUCOVORIN, The cancer journal from Scientific American, 4(1), 1998, pp. 12-18
Citation: Ss. Cao et al., INTERLEUKIN-15 PROTECTS AGAINST TOXICITY AND POTENTIATES ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL ALONE AND IN COMBINATION WITH LEUCOVORIN IN RATS BEARING COLORECTAL-CANCER, Cancer research, 58(8), 1998, pp. 1695-1699
Citation: Ss. Cao et al., INTERLEUKIN-15 OFFERS SELECTIVE PROTECTION FROM IRINOTECAN-INDUCED INTESTINAL TOXICITY IN A PRECLINICAL ANIMAL-MODEL, Cancer research, 58(15), 1998, pp. 3270-3274
Authors:
RUSTUM YM
HARSTRICK A
CAO SS
VANHOEFER U
YIN MB
WILKE H
SEEBER S
Citation: Ym. Rustum et al., THYMIDYLATE SYNTHASE INHIBITORS IN CANCER-THERAPY - DIRECT AND INDIRECT INHIBITORS, Journal of clinical oncology, 15(1), 1997, pp. 389-400
Citation: Ss. Cao et al., ROLE OF FLUOROPYRIMIDINE SCHEDULE AND (6R,S)LEUCOVORIN DOSE IN A PRECLINICAL ANIMAL-MODEL OF COLORECTAL-CARCINOMA, Journal of the National Cancer Institute, 88(7), 1996, pp. 430-436
Authors:
VANHOEFER U
CAO SS
MINDERMAN H
TOTH K
SKENDERIS BS
SLOVAK ML
RUSTUM YM
Citation: U. Vanhoefer et al., D,L-BUTHIONINE-(S,R)-SULFOXIMINE POTENTIATES IN-VIVO THE THERAPEUTIC EFFICACY OF DOXORUBICIN AGAINST MULTIDRUG-RESISTANCE PROTEIN-EXPRESSING TUMORS, Clinical cancer research, 2(12), 1996, pp. 1961-1968
Citation: Ss. Cao et al., 5-FLUOROURACIL PRODRUG - ROLE OF ANABOLIC AND CATABOLIC PATHWAY MODULATION IN THERAPY OF COLORECTAL-CANCER, Clinical cancer research, 1(8), 1995, pp. 839-845
Authors:
SPECTOR T
CAO SS
RUSTUM YM
HARRINGTON JA
PORTER DJT
Citation: T. Spector et al., ATTENUATION OF THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL BY (R)-5-FLUORO-5,6-DIHYDROURACIL, Cancer research, 55(6), 1995, pp. 1239-1241
Citation: Fa. Durrani et al., MODULATION OF THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL AND CISPLATINUM BY N-PHOSPHONACETYL-L-ASPARTATE IN THE MURINE COLON-CARCINOMA NUMBER-26, International journal of oncology, 5(5), 1994, pp. 1065-1068
Citation: Ss. Cao et al., 5-ETHYNYLURACIL (776C85) - MODULATION OF 5-FLUOROURACIL EFFICACY AND THERAPEUTIC INDEX IN RATS BEARING ADVANCED COLORECTAL-CARCINOMA, Cancer research, 54(6), 1994, pp. 1507-1510